Lactoferrin Market to reach the value of US$ 332.2 Mn in 2031 - FMI
Newly released data from lactoferrin market analysis by Future Market Insights shows that global consumption of lactofer…
Newly released data from lactoferrin market analysis by Future Market Insights shows that global consumption of lactofer…
InVitria announced expansion of its distribution network to include multiple regional and worldwide distributors. InVitr…
InVitria announces its attendance at the 22nd Annual European Society for Animal Cell Technology (ESACT) Conference in V…
InVitria and Lampire Biological are hosting a webinar to share a strategy to eliminate contaminating IgG’s from serum wh…
InVitria was recently cited in a review article titled "Recombinant human transferrin: Beyond iron binding and transport…
A recent study demonstrated that Cellastim® (recombinant human albumin) and Optiferrin® (recombinant human transferrin)…
InVitria announces that its Lysobac cell lysing reagent is manufactured at the Company's Junction City, Kansas facility…
InVitria announced the expansion of its sales and marketing team with the addition of Shawn Smith as Vice President, Sal…
A shift in the life science market has begun to steer cell culture scientists to reevaluate their use of native transfer…
InVitria is attending the 9th Annual Biological Production Forum in Frankfurt, Germany June 21st through the 23rd. This…